Association between renin-angiotensin aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction;Hafif ve orta derecede sol ventrikül disfonksiyonu olan hastalarda renin-anjiyotensin-aldosteron sistem blokerleri ile kalp cerrahisi sonrasi gelişen atrial fibrilasyon arasindaki ilişki

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 2, 2010, Pages 137-142

  Özaydin, Mehmet ^a   Varol, Ercan ^a   Tüker, Yasin ^a   Peker, Oktay ^b   Erdoǧan, Doǧan ^a   Doǧan, Abdullah ^a   Ibrişim, Erdǒan ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Gulkent Hospital   (Turkey)

Author keywords

Atrial fibrillation; Cardiac surgical procedures; Left ventricular systolic dysfunction; Predictive value of tests; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR;

ADULT; AGE; AGED; AORTA CLAMPING; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VALVE SURGERY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PREDICTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; DRUG ANTAGONISM; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PREDICTION AND FORECASTING; STATISTICAL MODEL; TREATMENT OUTCOME;

ADRENERGIC ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SPIRONOLACTONE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952524941     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.039     Document Type: Article

References (28)

1. Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 2008; 118: 1612-8.
2. Maisel WH, Rawn J, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-73.
3. Kalus JS, Coleman CI, White CM. The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol 2006; 46: 21-8.
4. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27: 512-8.
5. Biase MD, Troccoli R, Brunetti ND. Non-antiarrhythmic drugs for the prevention of cardiac arrhythmias. Ital Heart J 2005; 6: 175-9.
6. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a metaanalysis. J Am Coll Cardiol 2005; 45: 1832-9.
7. Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006; 152: 217-22.
8. Nattel S. Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management? Cardiovasc Res 2002; 54: 347-60.
9. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001; 104: 2608-14.
10. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107: 2926-31.
11. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, et al. CHARM Investigators Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J 2006; 151: 985-91.
12. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-80.
13. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-9.
14. White CM, Kluger J, Lertsburapa K, Faheem O, Coleman CI. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg 2007; 31: 818-21.
15. Rossi GP. Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists? Curr Hypertens Rep 2006; 8: 262-8.
16. Mac Fadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovas Res 1997; 35: 30-4.
17. Gao X, Peng L, Adhikari CM, Lin J, Zuo Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007; 13: 170-7.
18. Özaydin M, Doǧan A, Varol E, Kapan S, Tüzün N, Peker O, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007; 107: 117-21.
19. Wang W, McClaim JM, Zucker IH. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 1994; 24: 571-5.
20. Malik M for the Task Force of the ESC and NASPE. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-65.
21. Oral H, Chugh A, Scharf C, Hall B, Cheung P, Veerareddy S, et al. Pulmonary vein isolation for vagotonic, adrenergic, and random episodes of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15: 402-6.
22. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-8.
23. Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, Robidel E, et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 2005; 26: 2193-9.
24. Coleman CI, Makanji S, Kluger J, White CM. Effect of angiotensinconverting enzyme inhibitors or angiotensin receptor blockers on the frequency of post cardiothoracic surgery atrial fibrillation. Ann Pharmacother 2007; 41: 433-7.
25. Özaydin M, Dede O, Varol E, Kapan S, Türker Y, Peker O, et al. Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127: 362-7.
26. Madrid AH, Peng J, Zamora J, Marín I, Bernal E, Escobar C, et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials. Pacing Clin Electrophysiol 2004; 27: 1405-10.
27. Halonen J, Hakala T, Auvinen T, Karjalainen J, Turpeinen A, Uusaro A. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation 2006; 114 (Suppl): I-1-I-4.
28. Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery. A randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723-8.